现代医学背景下经方新用的关键问题探讨

丁齐又; 李青伟; 杨映映; 李修洋; 仝小林

doi:10.14148/j.issn.1672-0482.2023.0201

现代医学背景下经方新用的关键问题探讨

doi: 10.14148/j.issn.1672-0482.2023.0201

丁齐又^{1, 2,},
李青伟²,
杨映映³,
李修洋²,
仝小林^2, ,

1.
北京中医药大学研究生院，北京 100029
2.
中国中医科学院广安门医院，北京 100053
3.
中日友好医院国家中西医结合医学中心，北京 100029

基金项目:

中国科学院学部咨询评议项目 2021-ZW10-A-017

国家重点研发计划应急项目 2022YFC0868300

详细信息

作者简介:
丁齐又，女，博士研究生，E-mail：18811785685@163.com

仝小林中国科学院院士，中医内科学家，中国中医科学院首席研究员，广安门医院主任医师，长期致力于中医药传承与创新研究。聚焦于提高中医疗效这一核心问题，构建了核心病机-分类-分期-分证的中医诊疗新体系。在新冠肺炎疫情期间，担任中央指导组专家、国家中医药管理局医疗救治专家组组长，深度指导并广泛参与了中医药抗疫工作。曾获何梁何利科学与技术进步奖、两项国家科技进步二等奖、第二届全国创新争先奖章、“全国抗击新冠肺炎疫情先进个人”荣誉称号、2020年度“最美科技工作者”及第三届“转化医学创新奖”。编著《糖络杂病论》《方药量效学》《仝小林经方新用十六讲》《新冠肺炎中医诊疗与研究》等26部专著

通讯作者:
仝小林，男，中国科学院院士，主任医师, 主要从事现代中医诊疗体系及方药量效学构建的研究，E-mail：tongxiaolin@vip.163.com

中图分类号: R2-03
计量
- 文章访问数: 445
- HTML全文浏览量: 48
- PDF下载量: 63
- 被引次数: 0
出版历程
- 收稿日期: 2023-02-16
- 网络出版日期: 2023-03-21
- 发布日期: 2023-03-10

Exploring the Key Issues of the New Application of Jingfang in the Context of Modern Medicine

1.
Graduate School of Beijing University of Chinese Medicine, Beijing 100029, China
2.
Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China
3.
National Integrated Chinese and Western Medicine Center, China-Japan Friendship Hospital, Beijing 100029, China

摘要

摘要: 随着社会的发展，人类疾病谱已发生了极大的变化，相比于仲景年代，现代社会的老年病、代谢病、慢性病逐渐成为主流。如何运用经方治疗现代医学疾病已成为经方研究的一项主要课题。在现代医学背景下，经方新用面临许多难题，一方面传统经方依赖的辨证体系缺少对慢性病的全程认识，另一方面经方善于调节机体宏观状态，但对现代疾病的理化指标却缺少针对性，此外经方在现代医学疾病诊疗中的药用剂量规律尚不明确。因此，要实现经方新用，一方面需借鉴仲景“病-期-态”诊疗模式，重新对现代疾病进行中医诊疗体系的重构；另一方面需于传统中药理论中引入现代药理研究成果，实现经方的态靶同调，并进一步深化经方量效关系的研究，使经方更好地服务于现代疾病的临床诊疗。
- 经方新用 /
- 现代医学 /
- 中医诊疗体系重构 /
- 量效关系
Abstract: With the development of society, the human diseases spectrum has changed dramatically. Compared with the Zhang Zhong-jing era (the late Eastern Han dynasty), geriatric, metabolic, and chronic diseases have gradually become the main disease types in modern society. Thus, the application of Jingfang to treat modern diseases has become a major issue of Jingfang research. In the context of modern medicine, the new application of Jingfang is facing many difficulties. On the one hand, the traditional system of Chinese medicine diagnosis and treatment, on which Jingfang was based, lacks a full understanding of chronic diseases. On the other hand, Jingfang is good at regulating the macroscopic state of the body, but lacks specificity for the physical and chemical indicators of modern diseases. Besides, the dosage rules of Jingfang in the modern system of Chinese medicine diagnosis and treatment are still unclear. Therefore, in order to better apply Jingfang, it is necessary to restructure the Chinese medicine diagnosis and treatment system for modern diseases by referring to Zhang Zhong-jing's diagnosis and treatment model (disease-period-state). In addition, it is also necessary to introduce modern pharmacological achievements into traditional Chinese medicine theory to realize the synchronous regulation of the state and target of Jingfang, and further deepen the research on the dosage-effect relationship of Jingfang so that it can better serve the clinical diagnosis and treatment for modern diseases.
- new application of Jingfang /
- modern medicine /
- reconstruction of Chinese medicine diagnosis and treatment system /
- dose-effect relationship

HTML全文

参考文献(14)

[1]	仝小林, 周强, 刘文科. 经方新用的思索[J]. 中医杂志, 2011, 52(11): 901-903. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ201111003.htm TONG XL, ZHOU Q, LIU WK. Reflections on the new use of classical prescriptions[J]. J Tradit Chin Med, 2011, 52(11): 901-903. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ201111003.htm
[2]	张薛光, 张玲玲. 经方各家学说概论[J]. 中国中医基础医学杂志, 2010, 16(8): 633-635. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYJC201008002.htm ZHANG XG, ZHANG LL. Introduction to various theories of classical prescriptions[J]. Chin J Basic Med Tradit Chin Med, 2010, 16(8): 633-635. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYJC201008002.htm
[3]	张存悌. 李可学术思想探讨(下)[J]. 辽宁中医杂志, 2006, 33(11): 1491-1492. doi: 10.3969/j.issn.1000-1719.2006.11.086 ZHANG CT. Discussion on Li Ke's academic thought (Ⅱ)[J]. Liaoning J Tradit Chin Med, 2006, 33(11): 1491-1492. doi: 10.3969/j.issn.1000-1719.2006.11.086
[4]	傅延龄, 宋佳, 张林. 经方本原剂量问题源流[J]. 北京中医药大学学报, 2013, 36(5): 293-296. doi: 10.3969/j.issn.1006-2157.2013.05.001 FU YL, SONG J, ZHANG L. Origin of primitive dosage of classical formulas[J]. J Beijing Univ Tradit Chin Med, 2013, 36(5): 293-296. doi: 10.3969/j.issn.1006-2157.2013.05.001
[5]	姬航宇, 陈欣燕, 焦拥政, 等. 对药典规定中药饮片用量的分析[J]. 中国中药杂志, 2013, 38(7): 1095-1097. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZY201307038.htm JI HY, CHEN XY, JIAO YZ, et al. Analysis on dosage of traditional Chinese medicine decoction pieces stipulated in Chinese Pharmacopoeia[J]. China J Chin Mater Med, 2013, 38(7): 1095-1097. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZY201307038.htm
[6]	钱超尘. 仲景论广《伊尹汤液》考[J]. 江西中医学院学报, 2003, 15(2): 26-29. doi: 10.3969/j.issn.1005-9431.2003.02.008 QIAN CC. A textual research on yi Yin Tang Ye by Zhong Jing[J]. J Jiangxi Coll Tradit Chin Med, 2003, 15(2): 26-29. doi: 10.3969/j.issn.1005-9431.2003.02.008
[7]	王翼天, 魏秀秀, 赵林华, 等. 基于病证结合模式的经方新用探讨[J]. 中医杂志, 2019, 60(23): 2055-2057. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ201923018.htm WANG YT, WEI XX, ZHAO LH, et al. Discussion on the new application of the classic prescription based on the combination of disease and syndrome[J]. J Tradit Chin Med, 2019, 60(23): 2055-2057. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ201923018.htm
[8]	丁齐又, 郑玉娇, 苟筱雯, 等. 仝小林对《伤寒杂病论》两种诊疗模式的创新[J]. 中医学报, 2020, 35(9): 1838-1842. https://www.cnki.com.cn/Article/CJFDTOTAL-HNZK202009007.htm DING QY, ZHENG YJ, GOU XW, et al. Tong Xiaolin's innovation of two diagnosis and treatment models in Shanghan zabing Lun[J]. Acta Chin Med, 2020, 35(9): 1838-1842. https://www.cnki.com.cn/Article/CJFDTOTAL-HNZK202009007.htm
[9]	宋珏娴, 傅晓燕, 仝小林. 现代医学背景下中医诊疗体系的重构[J]. 中医杂志, 2018, 59(1): 6-9. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ201801003.htm SONG JX, FU XY, TONG XL. Reconstruction of Chinese medicine diagnosis and treatment system under the background of modern medicine[J]. J Tradit Chin Med, 2018, 59(1): 6-9. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ201801003.htm
[10]	XU J, LIAN FM, ZHAO LH, et al. Structural modulation of gut microbiota during alleviation of type 2 diabetes with a Chinese herbal formula[J]. ISME J, 2015, 9(3): 552-562.
[11]	仝小林, 焦拥政, 连凤梅, 等. 方药量效关系研究的关键问题与思考[J]. 环球中医药, 2012, 5(6): 401-404. https://www.cnki.com.cn/Article/CJFDTOTAL-HQZY201206003.htm TONG XL, JIAO YZ, LIAN FM, et al. Some thoughts about the key points in the research of the dose-response relationship[J]. Glob Tradit Chin Med, 2012, 5(6): 401-404. https://www.cnki.com.cn/Article/CJFDTOTAL-HQZY201206003.htm
[12]	闫韶花, 陈欣燕, 焦拥政, 等. 大承气汤治疗肠梗阻临床用量研究[J]. 中医杂志, 2013, 54(22): 1953-1956. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ201322021.htm YAN SH, CHEN XY, JIAO YZ, et al. Dose of Dachengqi Decoction for bowel obstruction in clinical practice[J]. J Tradit Chin Med, 2013, 54(22): 1953-1956. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ201322021.htm
[13]	何莉莎, 宋攀, 赵林华, 等. 方药量效关系临床研究概况[J]. 中医杂志, 2019, 60(1): 80-84. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ201901020.htm HE LS, SONG P, ZHAO LH, et al. Overview of clinical research on dose-effect relationship[J]. J Tradit Chin Med, 2019, 60(1): 80-84. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ201901020.htm
[14]	ZHA LH, HE LS, LIAN FM, et al. Clinical strategy for optimal traditional Chinese medicine (TCM) herbal dose selection in disease therapeutics: Expert consensus on classic TCM herbal formula dose conversion[J]. Am J Chin Med, 2015, 43(8): 1515-1524.

施引文献

资源附件(0)

访问统计

点击查看大图

计量

文章访问数: 445
HTML全文浏览量: 48
PDF下载量: 63
被引次数: 0

姓名
邮箱
手机号码
标题
留言内容
验证码

留言板

现代医学背景下经方新用的关键问题探讨

doi: 10.14148/j.issn.1672-0482.2023.0201

通讯作者:
仝小林，男，中国科学院院士，主任医师, 主要从事现代中医诊疗体系及方药量效学构建的研究，E-mail：tongxiaolin@vip.163.com

计量

Exploring the Key Issues of the New Application of Jingfang in the Context of Modern Medicine

计量

目录

留言板

现代医学背景下经方新用的关键问题探讨

doi: 10.14148/j.issn.1672-0482.2023.0201

通讯作者: 仝小林，男，中国科学院院士，主任医师, 主要从事现代中医诊疗体系及方药量效学构建的研究，E-mail：tongxiaolin@vip.163.com

计量

出版历程

Exploring the Key Issues of the New Application of Jingfang in the Context of Modern Medicine

计量

出版历程

目录

通讯作者:
仝小林，男，中国科学院院士，主任医师, 主要从事现代中医诊疗体系及方药量效学构建的研究，E-mail：tongxiaolin@vip.163.com